| 000 | 01869 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514170529.0 | ||
| 264 | 0 | _c20040405 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0022-510X | ||
| 024 | 7 |
_a10.1016/j.jns.2003.11.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKonagaya, Masaaki | |
| 245 | 0 | 0 |
_aClinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban. _h[electronic resource] |
| 260 |
_bJournal of the neurological sciences _cMar 2004 |
||
| 300 |
_a85-90 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmebicides _xadverse effects |
| 650 | 0 | 4 |
_aAutonomic Nervous System Diseases _xetiology |
| 650 | 0 | 4 |
_aBlindness _xetiology |
| 650 | 0 | 4 |
_aClioquinol _xadverse effects |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOptic Nerve Diseases _xchemically induced |
| 650 | 0 | 4 |
_aPeripheral Nerves _xphysiopathology |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSpinal Cord _xphysiopathology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMatsumoto, Akihisa | |
| 700 | 1 | _aTakase, Sadao | |
| 700 | 1 | _aMizutani, Tomohiko | |
| 700 | 1 | _aSobue, Gen | |
| 700 | 1 | _aKonishi, Tetsuro | |
| 700 | 1 | _aHayabara, Toshiyuki | |
| 700 | 1 | _aIwashita, Hiroshi | |
| 700 | 1 | _aUjihira, Takatoshi | |
| 700 | 1 | _aMiyata, Kazuaki | |
| 700 | 1 | _aMatsuoka, Yukihiko | |
| 773 | 0 |
_tJournal of the neurological sciences _gvol. 218 _gno. 1-2 _gp. 85-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jns.2003.11.007 _zAvailable from publisher's website |
| 999 |
_c14483677 _d14483677 |
||